In human melanoma cell line HBL, binding of the ligand to MC1R causes the transactivation of c-KIT leading to the ERK1/ERK2 mitogen-activated protein kinase (MAPK) pathway, resulting in decreased melanin formation, which is independent of cAMP [50]. The gene discussed is MAPK3; the disease is melanoma.